Tenax Therapeutics (TENX) Other Accumulated Expenses (2016 - 2017)
Historic Other Accumulated Expenses for Tenax Therapeutics (TENX) over the last 3 years, with Q3 2017 value amounting to $170711.0.
- Tenax Therapeutics' Other Accumulated Expenses fell 9477.99% to $170711.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $170711.0, marking a year-over-year decrease of 9477.99%. This contributed to the annual value of $4.4 million for FY2016, which is N/A changed from last year.
- According to the latest figures from Q3 2017, Tenax Therapeutics' Other Accumulated Expenses is $170711.0, which was down 9477.99% from $1.6 million recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Other Accumulated Expenses ranged from a high of $4.4 million in Q4 2016 and a low of $170711.0 during Q3 2017
- Moreover, its 3-year median value for Other Accumulated Expenses was $3.3 million (2016), whereas its average is $2.7 million.
- Per our database at Business Quant, Tenax Therapeutics' Other Accumulated Expenses skyrocketed by 7043.3% in 2016 and then crashed by 9477.99% in 2017.
- Tenax Therapeutics' Other Accumulated Expenses (Quarter) stood at $2.6 million in 2015, then skyrocketed by 70.43% to $4.4 million in 2016, then tumbled by 96.09% to $170711.0 in 2017.
- Its Other Accumulated Expenses stands at $170711.0 for Q3 2017, versus $1.6 million for Q2 2017 and $3.5 million for Q1 2017.